Seroprevalence of mumps before inclusion of mumps vaccination in the Iranian Expanded Programme on Immunization
EMHJ-Eastern Mediterranean Health Journal. 2009; 15 (2): 295-301
Dans Anglais
| IMEMR
| ID: emr-157326
ABSTRACT
The current target groups for measles, mumps and rubella vaccination in the Islamic Republic of Iran are children at 12 months and 4-6 years. A study of the age-specific seroprevalence of antibodies against mumps in children aged 3-18 years in Shahrekord aimed to establish the need for booster vaccinations to cover non-immune children. Of 338 children, 19.8% were seronegative. Age-specific seronegativity was 33.3%, 20.5% and 4.6% in age groups 7-11, 12-14 and 15-18 years respectively. To obtain herd immunity, we suggest that for the next 5 years children aged 7-11 years entering guidance school are selected as the main group for vaccination
Recherche sur Google
Indice:
Méditerranée orientale
Sujet Principal:
Immunoglobuline G
/
Test ELISA
/
Vaccin antiourlien
/
Études séroépidémiologiques
/
Études transversales
/
Facteurs âges
/
Rappel de vaccin
/
Oreillons
Type d'étude:
Étude de prévalence
Limites du sujet:
Femelle
/
Humains
/
Mâle
langue:
Anglais
Texte intégral:
East Mediterr Health J.
Année:
2009
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS